<--- Back to Details
First PageDocument Content
Bacillus Calmette-Guérin / Vaccines / Bladder cancer / Carcinoma / Immunotherapy / Carcinoma in situ / BCG as a treatment for bladder cancer / Transitional cell carcinoma / Medicine / Tuberculosis / Cancer treatments
Bacillus Calmette-Guérin
Vaccines
Bladder cancer
Carcinoma
Immunotherapy
Carcinoma in situ
BCG as a treatment for bladder cancer
Transitional cell carcinoma
Medicine
Tuberculosis
Cancer treatments

SUMMARY FOR BASIS OF APPROVAL REFERENCE NUMBER:

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1,04 MB

Share Document on Facebook

Similar Documents

Prog Health Sci 2012, Vol 2 , No1 Neurologic adverse events vaccination  Neurologic adverse events following vaccination Sienkiewicz D.*, Kułak W., Okurowska-Zawada B., Paszko-Patej G.  Department of Pediatric Rehabilit

Prog Health Sci 2012, Vol 2 , No1 Neurologic adverse events vaccination Neurologic adverse events following vaccination Sienkiewicz D.*, Kułak W., Okurowska-Zawada B., Paszko-Patej G. Department of Pediatric Rehabilit

DocID: 1gwOG - View Document

rccm2013101896OC

rccm2013101896OC

DocID: 1g3Ud - View Document

Downloaded from rspb.royalsocietypublishing.org on September 4, 2013  Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers Mark A. Chambers, Fiona Rogers, Richard J. Delah

Downloaded from rspb.royalsocietypublishing.org on September 4, 2013 Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers Mark A. Chambers, Fiona Rogers, Richard J. Delah

DocID: 1dtQn - View Document

Bulletin of the World Health Organization

Bulletin of the World Health Organization

DocID: 1b0YD - View Document

DELAWARE COLLEGE OF ART AND DESIGN I M M U N I ZA T I O N RECORD

DELAWARE COLLEGE OF ART AND DESIGN I M M U N I ZA T I O N RECORD

DocID: 19ypY - View Document